Purpose {#section0005}
=======

Respiratory viral infections are responsable of a significant morbidity in LTRs and have been considered a possible risk factor for chronic lung function decline. Aim of our study was to asses the incidence of viral respiratory infections in a cohort of 17 LTRs in the first post transplant year, and correlate BAL samples and naso-pharingeal secretions (NPS) findings with clinical, functional, and radiological data.

Methods and Materials {#section0010}
=====================

A total of 84 BAL samples and 16 NPS were analysed with direct immunofluorescence, shell vial cultures, and molecular assays.

Results {#section0015}
=======

The incidence of respiratory viral infection was 0.94 episodes per patient/year. In all a total of 16 isolates were collected from 10 LTR: 5 from NPS and and 11 from BAL: Rhinovirus (1 NPS, 4 BAL); Respiratory Syncytial Virus (2 NPS, 1 BAL), Metapneumovirus (1 NPS); Parainfluenza virus (1 BAL), human Coronavirus 229E (1 NPS) and OC43 (2 BAL), Herpesviruses (3 BAL). Nine of these 16 episodes were associated to respiratory symptoms (dyspnoea, cough, faringodynia, coriza) functional impairment (4 cases) and/or radiological signs (bibasilar infiltrates, ground glass alterations, small centrilobular opacities, pleural effusion). In addition, 4 pulmonary CMV infections were detected defined as a presence of CMV DNA \> 100.000 copies/ml of BAL fluids in absence of radiological and clinical signs. CMV infections were treated with a 21 days course of i.v. gancyclovir while RSV infections were treated with nebulized ribavirin. In all other episodes only symptomatic treatment was performed with complete remission within 2 weeks.

Conclusions {#section0020}
===========

The incidence of respiratory viral infection during the first post-transplant year was relatively high, however did not persistently affect graft function in this small cohort of LTRs.
